Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Benjamin Taylor Sophrosyne Capital’

meetme

3 Recent Moves by Benjamin Taylor’s Sophrosyne Capital

Benjamin J Taylor’s Sophrosyne Capital just reported three recent moves regarding Ventrus Biosciences Inc (NASDAQ:VTUS), MeetMe Inc (NYSEMKT:MEET),......(read more)
AcelRx Pharmaceuticals Inc

Why Is Joseph Edelman’s Hedge Fund So Bullish On AcelRx?

In a disclosure of its holdings, Joseph Edelman’s Perceptive Advisors made public that it currently owns 6.57 million shares of AcelRx Pharmaceuticals......(read more)
S&W Seed Company (NASDAQ:SANW)

Benjamin Taylor, Sophrosyne Capital Own 4.8% of S&W Seed

Benjamin Taylor, Sophrosyne Capital: S&W Seed Company (NASDAQ:SANW) recently was slightly reduced in the equity portfolio of Benjamin J Taylor......(read more)